Outset Medical names Brittni McGill as first Chief Nursing Officer

Published 30/07/2025, 14:50
Outset Medical names Brittni McGill as first Chief Nursing Officer

SAN JOSE, Calif. - Outset Medical, Inc. (NASDAQ:OM), a medical technology company with strong liquidity metrics and a current market capitalization of $311 million, has appointed Brittni McGill to the newly created position of Chief Nursing Officer, according to a press release issued Wednesday. McGill will lead clinical education and support programs for the dialysis nursing community. According to InvestingPro data, the company maintains a healthy balance sheet with more cash than debt and a robust current ratio of 8.37x.

McGill joins the medical technology company after an 18-year career in nursing and hospital executive roles. She previously managed clinical services for a 350-bed hospital, overseeing more than 1,400 employees and developing multiple clinical programs.

In her prior role, McGill led her hospital’s transition from outsourced to insourced dialysis services using Outset’s Tablo system. This change reportedly increased the successful treatment rate to 98% and reduced central line blood stream infections by 75%.

"Brittni is a forward-thinking, creative and results-driven nurse executive who brings deep expertise in driving cost effective, quality driven clinical transformation," said Dr. Michael Aragon, Chief Medical Officer at Outset Medical.

McGill is currently pursuing a Doctorate of Nursing Practice at Baylor University. She holds a Master’s degree in Nursing Administration from the University of Texas at Arlington and a Bachelor’s degree in Nursing from the University of Oklahoma.

Outset Medical develops the Tablo Hemodialysis System, which is FDA-cleared for use from hospitals to homes. The company describes the system as integrating water purification and on-demand dialysate production. With the company’s next earnings report due in just 7 days, investors can access comprehensive analysis and additional insights through InvestingPro’s detailed research reports, which include expert analysis of the company’s financial health, market position, and growth prospects.

In other recent news, Outset Medical Inc. reported a 5.6% year-over-year increase in revenue, reaching $29.8 million for the first quarter. This figure exceeded both Oppenheimer’s estimate of $28.3 million and the consensus estimate of $27.8 million. In a strategic move, Outset Medical appointed Renee Gaeta as its new Chief Financial Officer, succeeding Nabeel Ahmed. Gaeta, who previously held the CFO position at Shockwave Medical, will also manage the company’s Information Technology and Human Resources departments. BTIG analysts have maintained a Buy rating on the stock, expressing confidence in Gaeta’s leadership abilities.

Additionally, RBC Capital Markets raised its price target for Outset Medical to $21.00 from $14.00, reflecting a more optimistic valuation based on improved business performance. The company has also added healthcare veteran Kevin O’Boyle to its Board of Directors, where he will serve as chair of the Audit Committee. Oppenheimer analysts have maintained a Perform rating on the stock following these developments. Outset Medical continues to project revenues between $115 million and $125 million for 2025, with non-GAAP gross margins in the high-30% range.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.